WHO estimated that 1 in 10 medical products circulating in low- and middle-income countries is substandard or falsified.
Counterfeit and Substandard — Cancer Drugs in India
Fake and substandard cancer medicines are a documented problem in India. Knowing where the risk actually comes from — and what protects you — matters more than anything you can read on a label.
- It does happen — WHO and CDSCO have both documented counterfeit and substandard oncology medicines in the Indian supply chain.
- Generic is not the same as fake — A licensed generic has the same active ingredient and the same regulatory approval as the originator brand. Counterfeit is a different problem entirely.
- Price alone is not the giveaway — Some counterfeits are priced to match genuine medicine. An unusually low price is a warning sign, but a normal price does not confirm authenticity.
- Where it comes from is what matters — The supply chain is the protection. Receiving medicine through a licensed hospital or registered pharmacy removes most of the risk.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026
Yes, counterfeit and substandard cancer medicines are a documented problem in India. WHO and CDSCO have both identified them in circulation. The most reliable protection is receiving your medicine through a licensed hospital pharmacy, from a prescription given by your treating oncologist, with the batch number verified before use.
How is genuine cancer medicine different from a counterfeit?
| Feature | Genuine licensed medicine | Suspicious or potentially counterfeit |
|---|---|---|
| Source | Licensed hospital pharmacy or CDSCO-registered retail pharmacy | Unregistered vendor, online marketplace, or individual seller |
| Batch traceability | Batch number verifiable on manufacturer's portal or CDSCO Sugam | Cannot be verified, or verification returns no match |
| Packaging | Consistent print quality, no spelling errors, intact tamper-evident seals | Blurred or inconsistent print, spelling errors, damaged or missing seals |
| Security features | Hologram or track-and-trace code intact where required by the manufacturer | Missing, peeling, or non-functional hologram |
| Price | Within normal market range for that molecule and brand | Significantly below market — or matched to market to avoid suspicion |
| Labelling | Schedule H1 marking, CDSCO registration, manufacturer licence number visible | Missing Schedule H marking, absent licence number, or incorrect regulatory text |
| Dispensed with | Valid oncologist prescription, verified at the point of dispensing | Offered without a prescription, or prescription not checked |
What is the difference between counterfeit, substandard, and generic?
- Counterfeit medicine
- A medicine deliberately mislabelled about its identity, composition, or source. It may contain the wrong ingredient, the wrong amount, no active ingredient at all, or a harmful substitute.
- Substandard medicine
- A medicine that was genuinely manufactured but fails quality standards — typically a degraded active ingredient, incorrect dose, or contamination. Poor storage or handling after manufacture can also produce a substandard product.
- Spurious drug
- The Indian regulatory term under the Drugs and Cosmetics Act for a medicine falsely claiming to be a legitimate product. Counterfeits and falsified medicines fall under this category, and prosecution is possible.
- Generic medicine
- A medicine with the same active ingredient, dose, and formulation as the originator brand, approved by CDSCO to the same efficacy and safety standards. A licensed generic is not counterfeit by definition.
- Schedule H1
- A CDSCO classification requiring a prescription from a registered medical practitioner before dispensing. All chemotherapy agents fall into this category. A Schedule H1 medicine cannot legally be sold without a prescription.
What can you check before accepting cancer medicine?
- Confirm the medicine was dispensed from a licensed hospital pharmacy or CDSCO-registered retail pharmacy.
- Check that Schedule H or H1 is marked on the outer packaging.
- Verify the batch number on the manufacturer's website or the CDSCO Sugam portal before the first dose.
- Inspect the tamper-evident seal and security hologram — both should be intact and consistent with the brand.
- Keep the outer packaging until the full course is complete, in case a batch recall is issued.
- Tell your oncologist before administration if medicine was sourced from outside the hospital.
- Refuse any offer of cancer medicine without a prescription, or at a price that seems implausibly low.
Who should not receive chemotherapy?
Chemotherapy is not appropriate in a number of situations where risk outweighs likely benefit. Eligibility is always decided by an oncologist on the basis of your individual case.
- Severely impaired kidney or liver function that cannot clear the drug safely.
- Active serious infection — chemotherapy further suppresses immunity and can make infection life-threatening.
- Very poor performance status, where the body is unlikely to tolerate treatment.
- Pregnancy, for most agents — cytotoxic drugs carry teratogenic risk; use during pregnancy requires specialist multidisciplinary review.
- Cancer types or stages where surgery, radiotherapy, or surveillance is the appropriate standard of care.
- Documented severe hypersensitivity to the specific agent.
- Certain cardiac conditions, depending on the agent involved.
Does counterfeit cancer medicine actually exist in India?
Yes. WHO and CDSCO have both documented falsified and substandard oncology medicines in circulation in India and across the broader South Asian market. This is not a theoretical concern.
Chemotherapy that contains the wrong active ingredient, a degraded compound, or no active ingredient at all has been identified. High-value oncology medicines are among the most targeted product categories globally, according to the WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products.
The most common entry point is informal procurement — buying outside a licensed hospital pharmacy, through online intermediaries, or from sellers offering large discounts. The formal supply chain is not immune, but the risk is substantially lower when each step can be traced.
What actually protects you — and what does not?
Most counterfeits are made to look right. The label, the colour of the liquid, and the outer box are not reliable ways to tell the difference on their own.
The most reliable protection is structural: receiving your medicine through a licensed hospital pharmacy, dispensed against a verified prescription, from a batch that can be traced to an authorised distributor. That chain of custody is what a counterfeit cannot replicate.
Batch-number verification on the manufacturer's portal or CDSCO Sugam is a step you can take yourself if you have any doubt. Your pharmacist should be able to show you the batch record on request. If they cannot, that is itself worth raising with your oncologist.
Did you know?
Oncology medicines are among the most targeted categories because of their high unit value — a single vial can be worth tens of thousands of rupees, making the incentive to counterfeit large.
Source: WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products, 2017
Explore 74 more Chemotherapy and Supportive Medicines by Name topics
Generic, Branded & Biosimilar Chemotherapy in India
- Amrit Pharmacy and Subsidised Cancer Drugs
- Biosimilars: Quality, Regulation and Price
- Can You Buy Chemotherapy Drugs Yourself?
- Cold Chain and Drug Storage: Why It Matters
- Counterfeit and Substandard Cancer Drugs
- Generic vs Branded Chemotherapy in India
- How to Check a Chemotherapy Drug Is Approved
- Is Generic Chemotherapy Safe?
- Jan Aushadhi and Government Pharmacy Options
- Patient Assistance Programmes for Cancer Drugs
- Price Control on Cancer Drugs in India
- Questions to Ask About the Drugs You Are Given
- Rituximab Biosimilars in India
- Trastuzumab Biosimilars in India
- Who Chooses the Brand Used for Your Treatment?
- Why the Same Drug Costs Ten Times More
Chemotherapy Drugs by Name
- 5-Fluorouracil (5-FU, Fluracil): What to Expect
- Bleomycin (Bleocip): What to Expect
- Capecitabine (Xeloda, Capegard, Xabine): The Tablet Form
- Carboplatin (Carboplat, Kemocarb): What to Expect
- Chemotherapy Drug Classes Explained
- Chemotherapy Drug Cost by Name
- Chemotherapy Drugs: A Complete Guide by Name
- Cisplatin (Cisplan, Kemoplat): What to Expect
- Cyclophosphamide (Endoxan, Cycloxan): What to Expect
- Cytarabine (Cytosar): What to Expect
- Docetaxel (Taxotere, Docetax, Daxotel): What to Expect
- Doxorubicin (Adrim, Adriamycin): The Red Injection
- Epirubicin: What to Expect
- Etoposide (Etosid, Fytosid): What to Expect
- Gemcitabine (Gemcite, Gemtaz, Oncogem): What to Expect
- Ifosfamide (Holoxan) and Mesna: Why They Go Together
- Irinotecan (Irinotel): What to Expect
- Liposomal Doxorubicin (Lipodox, Caelyx): How It Differs
- Methotrexate (Folitrax): What to Expect
- Mitomycin, Actinomycin and Less Common Agents
- Nab-Paclitaxel (Abraxane, Nabtaxel): How It Differs
- Oxaliplatin (Oxaliplat, Dacotin): What to Expect
- Paclitaxel (Paclitax, Intaxel, Oncotaxel): What to Expect
- Pemetrexed (Alimta, Pemgem, Pemnat): What to Expect
- Reading Your Chemotherapy Chart
- Temozolomide (Temodal, Temoget): The Brain Tumour Tablet
- Vincristine (Cytocristin, Oncovin): What to Expect
- Vinorelbine (Navelbine): What to Expect
- Which Drugs Affect Fertility?
- Which Drugs Affect the Heart, Kidneys or Lungs?
- Which Drugs Cause Hair Loss and Which Do Not?
- Which Drugs Cause Nausea and How Much?
- Which Drugs Cause Neuropathy?
- Why Was This Particular Drug Chosen for Me?
Drug Interactions, TB & Chronic Medicines
HUB — Chemotherapy Drugs by Name
HUB — Generic, Branded and Biosimilar Chemotherapy in India
HUB — Supportive Medicines Used With Chemotherapy
Supportive Medicines by Name
- Acid Blockers (Pantocid, Rantac) During Chemotherapy
- Allopurinol and Tumour Lysis Prevention
- Antibiotics and Antifungals During Chemotherapy
- Aprepitant (Aprecap, Emend) for Delayed Nausea
- Ayurvedic and Herbal Medicines Alongside Chemotherapy
- Cost of Supportive Medicines Across a Course
- Dexamethasone (Dexona) During Chemotherapy
- Emeset and Ondansetron for Chemotherapy Nausea
- Erythropoietin Injections for Low Haemoglobin
- Filgrastim (Grafeel, Neukine) Injections for Low Counts
- Leucovorin: Rescue and Modulation
- Long-Acting Growth Factor (Peg-Grafeel, Neulastim)
- Loperamide (Eldoper) for Chemotherapy Diarrhoea
- Mesna: Protecting the Bladder
- Mouthwashes and Mouth Care Medicines
- Painkillers That Are Safe During Chemotherapy
- Palonosetron and Longer-Acting Anti-Emetics
- The Medicines You Go Home With After Chemotherapy
- Vitamins and Supplements During Chemotherapy
- Why You Must Not Take Paracetamol Before Checking Your Temperature
Frequently asked questions
How do I know if the cancer medicine I received is genuine?
The most reliable check is traceability, not appearance. Verify the batch number on the manufacturer's website or the CDSCO Sugam portal — a genuine batch will return a match with the product name, manufacturer, and expiry. Also check that the Schedule H1 marking is present, the tamper-evident seal is intact, and the medicine was dispensed from a licensed pharmacy against your oncologist's prescription. If any of these checks fail, tell your oncologist before any dose is administered.
Is buying cancer medicine online safe?
Buying chemotherapy online without a verified prescription from a registered medical practitioner is not permitted under Indian law, and the supply chain for online sales is difficult to verify. CDSCO alerts have specifically flagged online platforms as a route for substandard and falsified oncology medicines. The safe route is a licensed hospital pharmacy that sources from an authorised distributor and reconciles each batch against your prescription before dispensing.
What is the difference between a generic cancer drug and a fake one?
A generic medicine is a different thing from a counterfeit. A CDSCO-approved generic contains the same active ingredient, in the same dose and formulation, meeting the same quality standard as the originator brand. A counterfeit is a deliberate fraud: wrong ingredient, wrong amount, or no active ingredient at all. Choosing between a licensed generic and an originator brand is a clinical and financial conversation to have with your oncologist and pharmacist. Accepting medicine from an unverifiable source is the risk, regardless of which name is on the label.
Why is there such a large price difference between two versions of the same molecule?
Originator brands carry the cost of original clinical development and the first regulatory approval globally. Licensed generics enter after patent expiry with lower development costs, which is why they are often significantly cheaper. A large difference between an originator and a well-established generic is normal and expected. A price that undercuts even the generic by a substantial margin — particularly from an informal source — is a warning sign, because there is no legitimate cost structure that explains it.
What should I do if I think I received a substandard or counterfeit medicine?
Tell your oncologist the same day, before any further doses are given. Keep the packaging, the vial or box, and any receipt or documentation of where it came from. Your oncologist can report it to CDSCO through the Pharmacovigilance Programme of India and escalate if there is a patient safety concern. Do not return it to the seller or dispose of it yourself before the oncology team has reviewed the situation.
Does CDSCO take action against counterfeit cancer drugs?
Yes. CDSCO publishes alerts for spurious, substandard, and misbranded medicines and coordinates enforcement with State Drug Controllers. The CDSCO Sugam portal allows batch-number verification for a range of products. Recall orders are issued when a batch fails quality testing. Enforcement is uneven across states and the system is not comprehensive, but documented counterfeits in the Indian market have been actioned. Current drug alerts are published on the official CDSCO website.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.